SITE007-0217

SITE007 (JPN) › SITE007-0217

SITE007-0217

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE007 (JPN) · Dr. Dubois
consented 2026-05-16

enrolled

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-06 (study day 100); relationship: not assessed

mild assessed

Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-12-28 (study day 32); relationship: RELATED

moderate assessed

Grade 1 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-12-12 (study day 16); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.